Published in Int J Chron Obstruct Pulmon Dis on October 16, 2012
COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09
Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One (2014) 1.04
Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract (2014) 0.91
Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: psychological determinants: a cross-sectional study. Health Qual Life Outcomes (2013) 0.90
Early telemedicine training and counselling after hospitalization in patients with severe chronic obstructive pulmonary disease: a feasibility study. BMC Med Inform Decis Mak (2015) 0.84
Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med (2014) 0.83
The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis (2014) 0.80
Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.78
Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study. Int J Chron Obstruct Pulmon Dis (2015) 0.78
The effect of comorbidities on COPD assessment: a pilot study. Int J Chron Obstruct Pulmon Dis (2015) 0.78
The relationships of self-efficacy, physical activity, and paid work to health-related quality of life among patients with chronic obstructive pulmonary disease (COPD). J Multidiscip Healthc (2014) 0.78
Advantage of impulse oscillometry over spirometry to diagnose chronic obstructive pulmonary disease and monitor pulmonary responses to bronchodilators: An observational study. SAGE Open Med (2015) 0.78
Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Prefer Adherence (2015) 0.77
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity. Int J Chron Obstruct Pulmon Dis (2015) 0.76
Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Drug development for airway diseases: looking forward. Nat Rev Drug Discov (2015) 0.75
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Preventing COPD exacerbations: new options for a crucial and growing problem. Fed Pract (2014) 0.75
Comparison of laboratory- and field-based exercise tests for COPD: a systematic review. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect. Int J Chron Obstruct Pulmon Dis (2014) 0.75
The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease. Respir Res (2013) 0.75
Assessing upper-extremity motion: An innovative method to quantify functional capacity in patients with chronic obstructive pulmonary disease. PLoS One (2017) 0.75
Dialectal influence on chronic pulmonary disease assessment test: the reliability and validity study. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD). Health Qual Life Outcomes (2016) 0.75
The mental health of asbestos-exposed subjects with pleural abnormalities. Int Arch Occup Environ Health (2014) 0.75
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes (2006) 26.32
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Measuring health-related quality of life. Ann Intern Med (1993) 11.84
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
A questionnaire for the assessment of leisure time physical activities. J Chronic Dis (1978) 10.20
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05
Assesment of quality-of-life outcomes. N Engl J Med (1996) 8.66
Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 3.61
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 3.58
Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003) 3.44
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax (2003) 2.93
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest (2007) 2.67
Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest (1998) 2.57
Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med (1997) 2.45
Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J (2011) 2.38
Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest (2012) 2.34
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD (2005) 2.12
Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med (2010) 2.09
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax (2001) 1.89
Symptoms and experiences in chronic bronchitis and emphysema. Chest (1983) 1.81
Exacerbations of chronic obstructive pulmonary disease. Respir Care (2003) 1.80
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J (2006) 1.77
Issues concerning health-related quality of life in COPD. Chest (1995) 1.64
Using the Rasch model in nursing research: an introduction and illustrative example. Int J Nurs Stud (2008) 1.58
Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD (2004) 1.58
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
COPD as a systemic disease: impact on physical functional limitations. Am J Med (2008) 1.57
The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS). Aliment Pharmacol Ther (2004) 1.55
The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax (2011) 1.54
Changes in health status, psychological distress, and quality of life in COPD patients after hospitalization. Qual Life Res (2006) 1.52
Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J (2006) 1.52
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax (2009) 1.50
Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J (2011) 1.45
Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors. Clin Sci (Lond) (1990) 1.45
COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health (2011) 1.39
Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Stroke (1997) 1.38
Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful? Proc Am Thorac Soc (2005) 1.37
Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies. Health Qual Life Outcomes (2004) 1.37
Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest (2002) 1.27
Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) (2010) 1.26
Depressive symptoms as predictors of mortality in patients with COPD. Chest (2008) 1.25
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J (2009) 1.24
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med (2000) 1.24
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health (2010) 1.21
Patient's perception of exacerbations of COPD--the PERCEIVE study. Respir Med (2006) 1.21
Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med (2006) 1.18
Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J (1991) 1.15
Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study. Value Health (2002) 1.08
Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest (2010) 1.07
Content comparison of health-related quality of life instruments for COPD. Respir Med (2007) 1.05
Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest (2010) 1.04
Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest (2007) 1.03
Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res (2010) 0.98
Prevalence of sleep-related symptoms in a primary care population - their relation to asthma and COPD. Prim Care Respir J (2007) 0.96
A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value Health (2009) 0.95
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health Qual Life Outcomes (2013) 0.95
Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care (2010) 0.94
'Am I going to see the next morning?' A qualitative study of patients' perspectives of sleep in COPD. Prim Care Respir J (2007) 0.94
Evaluation of a daily activity diary for chronic pain patients. Pain (1984) 0.94
Relationship between symptoms and functional performance in COPD. Res Nurs Health (2005) 0.94
Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes (2003) 0.94
Management of COPD exacerbations. Am Fam Physician (2010) 0.93
A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). Prim Care Respir J (2004) 0.93
The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute). Cough (2011) 0.91
Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax (2009) 0.91
Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures. Curr Med Res Opin (2007) 0.88
Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD. Health Qual Life Outcomes (2011) 0.87
Assessment of dyspnea in asthma: validation of The Dyspnea-12. J Asthma (2011) 0.86
Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin (2011) 0.86
Subjective measurement of activity in chronic obstructive pulmonary disease. COPD (2007) 0.84
Quantifying of severity of exacerbations in chronic obstructive pulmonary disease: adaptations to the definition to allow quantification. Proc Am Thorac Soc (2007) 0.84
Prevention of exacerbations of COPD with pharmacotherapy. Eur Respir Rev (2010) 0.83
Development and validation of the living with chronic obstructive pulmonary disease questionnaire. Qual Life Res (2011) 0.83
A multidimensional computer adaptive test approach to dyspnea assessment. Arch Phys Med Rehabil (2011) 0.83
Methodological issues in evaluating measures of health as outcomes for COPD. Eur Respir J Suppl (2003) 0.82
Couples' ratings of chronic obstructive pulmonary disease patients' quality of life. Clin Nurs Res (2003) 0.82
The comparison of different dyspnoea scales in patients with COPD. J Eval Clin Pract (2006) 0.81
Fatigue and disability in elderly patients with chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr (2010) 0.80
A new questionnaire specifically designed for patients affected by chronic obstructive pulmonary disease; The Italian Health Status Questionnaire. Respir Med (2005) 0.80
Evaluation of male COPD patients' health status by proxies. Respir Med (2006) 0.80
Experience of using the CRQ (Chronic Respiratory Questionnaire). Respir Med (1991) 0.79
Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns (2010) 0.79
Portuguese-language version of the Chronic Respiratory Questionnaire: a validity and reproducibility study. J Bras Pneumol (2009) 0.79
Effect of depression care on outcomes in COPD patients with depression. Chest (2008) 0.78
Measuring cough severity: development and pilot testing of a new seven-item cough severity patient-reported outcome measure. Ther Adv Respir Dis (2010) 0.78
Reliability and validity of the Taiwan (Mandarin Chinese) version of the chronic respiratory questionnaire. Qual Life Res (2011) 0.77
[The validity and sensitivity to change of the Spanish self-administered version of the chronic respiratory questionnaire (CRQ-SAS)]. Arch Bronconeumol (2011) 0.76
Chronic obstructive pulmonary disease. Lancet (2012) 4.43
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 3.61
Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.41
Symptom-based questionnaire for identifying COPD in smokers. Respiration (2005) 2.18
Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J (2012) 2.18
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J (2011) 1.81
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res (2010) 1.79
The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J (2010) 1.76
Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol (2012) 1.68
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J (2011) 1.68
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration (2012) 1.62
The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance. J Antimicrob Chemother (2008) 1.60
Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J (2013) 1.57
New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med (2011) 1.56
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest (2013) 1.51
Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51
Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol (2011) 1.50
Prescribing of asthma medication in primary care for children aged under 10. Prim Care Respir J (2010) 1.50
Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol (2013) 1.47
Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol (2013) 1.45
Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J (2011) 1.45
Symptom-based questionnaire for differentiating COPD and asthma. Respiration (2005) 1.43
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. Prim Care Respir J (2012) 1.43
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics (2005) 1.42
[Variability of antibiotic prescribing for respiratory tract infections in two European countries]. Enferm Infecc Microbiol Clin (2005) 1.39
Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc (2006) 1.32
Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep (2011) 1.28
The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med (2012) 1.26
Cognitive performance in patients with COPD. Respir Med (2004) 1.26
The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med (2015) 1.25
Improving physical activity in COPD: towards a new paradigm. Respir Res (2013) 1.20
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res (2010) 1.14
Determinants of Underdiagnosis of COPD in National and International Surveys. Chest (2015) 1.14
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. Eur J Health Econ (2007) 1.13
Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes (2010) 1.10
COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.08
UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J (2010) 1.07
The general public's knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes. Arch Bronconeumol (2012) 1.06
Respiratory guidelines--which real world? Ann Am Thorac Soc (2014) 1.01
Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med (2011) 1.01
Factors associated with high healthcare resource utilisation among COPD patients. Respir Med (2012) 1.01
COPD symptoms in the morning: impact, evaluation and management. Respir Res (2013) 1.00
Poor communication may impair optimal asthma care: a qualitative study. Fam Pract (2006) 0.99
[Impact of chronic obstructive pulmonary disease on activities of daily living: results of the EIME multicenter study]. Arch Bronconeumol (2007) 0.98
Adherence to inhaled corticosteroid use and local adverse events in persistent asthma. Am J Manag Care (2008) 0.97
[Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]. Arch Bronconeumol (2010) 0.96
Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest (2013) 0.95
Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J (2013) 0.95
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. J Infect (2013) 0.94
Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim Care Respir J (2012) 0.94
The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challenges. Pharmacoepidemiol Drug Saf (2008) 0.93
Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis. Respir Med (2006) 0.93
A new perspective on optimal care for patients with COPD. Prim Care Respir J (2011) 0.92
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res (2012) 0.92
Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf (2008) 0.92
Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol (2003) 0.92
Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J (2006) 0.92
Detection of polymorphisms at exons 3 (Tyr113-->His) and 4 (His139-->Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem (2002) 0.91
Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J (2012) 0.91
Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest (2005) 0.90
[Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol (2006) 0.90
Rare alpha-1-antitrypsin variants: are they really so rare? Ther Adv Respir Dis (2012) 0.90
Air travel for patients with chronic obstructive pulmonary disease: a case report. Br J Gen Pract (2012) 0.90
The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity. Health Qual Life Outcomes (2013) 0.90
Putting health status guided COPD management to the test: protocol of the MARCH study. BMC Pulm Med (2013) 0.89
[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]. Arch Bronconeumol (2006) 0.89
Compliance with guidelines in the treatment of asthma exacerbations in primary care. Ther Adv Respir Dis (2011) 0.89
Variability of respiratory symptoms in severe COPD. Arch Bronconeumol (2011) 0.89
Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.88
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. Pulm Pharmacol Ther (2008) 0.88
Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology (2013) 0.88
Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens. Am J Respir Crit Care Med (2002) 0.87
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. Int J Chron Obstruct Pulmon Dis (2011) 0.87
Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res (2012) 0.86
Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med (2013) 0.86
A systematic review of the role of vitamin insufficiencies and supplementation in COPD. Respir Res (2010) 0.86
Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes (2014) 0.86
A study of adherence to antibiotic treatment in ambulatory respiratory infections. Int J Infect Dis (2012) 0.85
A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir Res (2006) 0.85
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach. Orphanet J Rare Dis (2013) 0.85
Medical students' and teachers' perceptions of sexual misconduct in the student-teacher relationship. Perspect Med Educ (2013) 0.85
Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest (2005) 0.84
Chronic bronchial infection in COPD. Is there an infective phenotype? Respir Med (2012) 0.84
Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res (2004) 0.83
Which characteristics of written feedback are perceived as stimulating students' reflective competence: an exploratory study. BMC Med Educ (2013) 0.83
Improving physical activity in patients with COPD with urban walking circuits. Respir Med (2013) 0.83
Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulm Med (2014) 0.83
Patient-reporting of side effects may provide an important source of information in clinical practice. Eur J Clin Pharmacol (2007) 0.82
The overlap phenotype: the (missing) link between asthma and COPD. Multidiscip Respir Med (2012) 0.82
Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study. Respir Med (2010) 0.82
Interactive Monitoring Service and COPD: Is it Possible to Reduce Nonadherence? COPD (2014) 0.82
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. Eur Respir J (2012) 0.82